U.S., Nov. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07917442) titled 'Evaluation of the Prevalence, and Immunological Characteristics of Small Fiber Neuropathy in... Read More
U.S., Nov. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07916870) titled 'Photodynamic Therapy Combined With a Self-expandable Radioactive Particle-loaded Biliary Ste... Read More
U.S., Nov. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07917455) titled 'Plasma Concentration Monitoring of Direct Oral Anticoagulants in Emergency Department Patien... Read More
U.S., Nov. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07914907) titled 'GenAI-Assisted Rheumatoid Arthritis Bone Erosion Risk Assessment and DMARD Selection' on Oct... Read More
U.S., Nov. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07915440) titled 'Application of Meaning-Based Psychotherapy to a Sample of Patients With Chronic Pain' on Oct... Read More
U.S., Nov. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07917351) titled 'AI-Assisted Whole-Course Management for Medication Safety and Healthcare Burden in Advanced ... Read More
U.S., Nov. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07915180) titled 'Boys Sexual Health' on Sept. 30. Brief Summary: Sexual health among young people is an impo... Read More
U.S., Nov. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07917390) titled 'ALT-100 Monoclonal Antibody (mAb) in Bone-Predominant Metastatic Androgen Pathway Modulation... Read More
U.S., Nov. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07917624) titled 'Prophylactic Strategies for Mitigating Central Nervous System Relapse in Diffuse Large B-Cel... Read More
Singapore, Nov. 5 -- The Health Sciences Authority received information related to the study titled 'A Phase II, Open-label Platform Study of Osimertinib in Combination with Anti-cancer Agents in Part... Read More